KRT19 and carcinoma: Pathology: poorly differentiated carcinoma, additional biopsies taken. Homogeneous mononuclear cells, positive immunohistochemical markers (CK, CK7, CK19, GATA3, MUC4, etc.), high PD-L1 score, low MSS and TMB.